Literature DB >> 18211920

Identification of beta1,4GalT II as a target gene of p53-mediated HeLa cell apoptosis.

Jin Zhou1, Yuanyan Wei, Dan Liu, Xuqing Ge, Fengbiao Zhou, Xiaojing Yun Jianhai Jiang, Jianxin Gu.   

Abstract

beta1,4-galactosyltransferase II (beta1,4GalT II) is one of the enzymes transferring galactose to the terminal N-acetylglucosamine of complex-type N-glycans. Previously, we have reported that beta1,4GalT II overexpression increased cisplatin-induced HeLa cell apoptosis. However, the mechanisms of its expression regulation have been rarely investigated. Here, we cloned the 1.8-kb 5'-flanking region of the beta1,4GalT II gene and analysed its promoter activity. The transcriptional activity and mRNA expression level of beta1,4GalT II were dramatically induced by p53 transcription factor in HeLa cells. In response to DNA damage agent adriamycin, the mRNA expression and promoter activity of beta1,4GalT II were significantly up-regulated and the binding of p53 to beta1,4GalT II promoter was obviously increased. Furthermore, decreasing the expression of beta1,4GalT II using RNA interference inhibited p53-mediated HeLa cell apoptosis induced by adriamycin. Collectively, these results suggested that beta1,4GalT II might serve as a target gene of p53 transcription factor during adriamycin-induced HeLa cell apoptosis, which elucidated a new mechanism of p53-mediated cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18211920     DOI: 10.1093/jb/mvn003

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

1.  Enhanced expression of the β4-galactosyltransferase 2 gene impairs mammalian tumor growth.

Authors:  M Tagawa; K Shirane; L Yu; T Sato; S Furukawa; H Mizuguchi; R Kuji; K Kawamura; N Takahashi; K Kato; S Hayakawa; S Sawada; K Furukawa
Journal:  Cancer Gene Ther       Date:  2014-06-06       Impact factor: 5.987

2.  Long-read sequencing unveils high-resolution HPV integration and its oncogenic progression in cervical cancer.

Authors:  Liyuan Zhou; Qiongzi Qiu; Qing Zhou; Jianwei Li; Mengqian Yu; Kezhen Li; Lingling Xu; Xiaohui Ke; Haiming Xu; Bingjian Lu; Hui Wang; Weiguo Lu; Pengyuan Liu; Yan Lu
Journal:  Nat Commun       Date:  2022-05-10       Impact factor: 17.694

3.  B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1.

Authors:  H Zhou; H Ma; W Wei; D Ji; X Song; J Sun; J Zhang; L Jia
Journal:  Cell Death Dis       Date:  2013-06-06       Impact factor: 8.469

Review 4.  Challenge to the suppression of tumor growth by the β4-galactosyltransferase genes.

Authors:  Kiyoshi Furukawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2015       Impact factor: 3.493

5.  Mechanistic interpretation of non-coding variants for discovering transcriptional regulators of drug response.

Authors:  Xiaoman Xie; Casey Hanson; Saurabh Sinha
Journal:  BMC Biol       Date:  2019-07-30       Impact factor: 7.431

6.  Identification of a Novel Glycosyltransferase Prognostic Signature in Hepatocellular Carcinoma Based on LASSO Algorithm.

Authors:  Zhiyang Zhou; Tao Wang; Yao Du; Junping Deng; Ge Gao; Jiangnan Zhang
Journal:  Front Genet       Date:  2022-03-09       Impact factor: 4.599

7.  A high-density genetic map and growth related QTL mapping in bighead carp (Hypophthalmichthys nobilis).

Authors:  Beide Fu; Haiyang Liu; Xiaomu Yu; Jingou Tong
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

8.  Biochemical and functional characterization of glycosylation-associated mutational landscapes in colon cancer.

Authors:  Srividya Venkitachalam; Leslie Revoredo; Vinay Varadan; Ryan E Fecteau; Lakshmeswari Ravi; James Lutterbaugh; Sanford D Markowitz; Joseph E Willis; Thomas A Gerken; Kishore Guda
Journal:  Sci Rep       Date:  2016-03-23       Impact factor: 4.379

9.  Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma.

Authors:  Huyang Xie; Yu Zhu; Huimin An; Hongkai Wang; Yao Zhu; Hangcheng Fu; Zewei Wang; Qiang Fu; Jiejie Xu; Dingwei Ye
Journal:  Oncotarget       Date:  2016-05-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.